Dacsted 500mg Injection

About

Dacarbazine, often marketed under names like Dacsted, is an alkylating agent used in the treatment of various cancers, most notably malignant melanoma and Hodgkin's lymphoma. As a cytotoxic chemotherapy drug, it exerts its antineoplastic effect by alkylating DNA, which leads to DNA strand breaks and inhibition of DNA replication and transcription. This ultimately results in cell cycle arrest and apoptosis of rapidly proliferating cancer cells. Dacarbazine is a prodrug that requires metabolic activation in the liver to its active form.

It is typically administered intravenously and is often used as part of multi-drug regimens. In malignant melanoma, it has been a standard treatment for metastatic disease, sometimes combined with other agents. For Hodgkin's lymphoma, it is a key component of the ABVD regimen (Adriamycin, Bleomycin, Vinblastine, Dacarbazine), which is a widely used and effective first-line therapy. Despite its side effects, its established efficacy in these specific cancers makes it an important agent in oncology.

Uses

• Treatment of metastatic malignant melanoma.
• Treatment of Hodgkin's lymphoma as part of a combination regimen (e.g., ABVD).
• Treatment of soft tissue sarcomas (less common).
• Treatment of neuroblastoma (less common).

Directions For Use

Dacsted Injection is administered intravenously by a healthcare professional. The dosage and infusion rate are determined by your doctor based on your condition and body surface area.

Benefits

• Effective in treating metastatic malignant melanoma.
• Key component of effective Hodgkin's lymphoma regimens.
• Well-established efficacy in its indicated uses.
• Can induce remission in sensitive cancers.
• Contributes to improved survival in specific lymphomas.
• Part of standard-of-care protocols for certain malignancies.

Side Effects

• Severe nausea and vomiting (highly emetogenic)
• Myelosuppression (leukopenia, thrombocytopenia, anemia)
• Flu-like syndrome (fever, myalgia, malaise)
• Anorexia
• Diarrhea
• Alopecia (hair loss)
• Photosensitivity
• Hepatotoxicity (veno-occlusive disease of the liver)
• Renal impairment
• Injection site pain
• Facial flushing
• Paresthesia

Safety Measures

• Alcohol - Avoid alcohol as it may exacerbate nausea, vomiting, and potential liver toxicity.
• Pregnancy - Dacarbazine is teratogenic and contraindicated in pregnancy. Effective contraception is required for both male and female patients.
• Breastfeeding - Breastfeeding is contraindicated during Dacarbazine treatment due to potential harm to the infant.
• Liver - Use with extreme caution in patients with hepatic impairment; dose reduction may be necessary. Monitor liver function closely due to risk of veno-occlusive disease.
• Kidney - Use with caution in patients with renal impairment; dose reduction may be necessary. Monitor kidney function closely.
• Lung - No specific lung toxicity is commonly associated, but general monitoring for respiratory symptoms is advised, especially in combination therapies.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.